AOD-9604 10mg

For research purposes only, this product is not intended for human consumption, diagnosis, or treatment. It has not been approved by the FDA or MHRA. Sales are limited to qualified researchers and institutions, and misuse could lead to account termination or legal consequences.

AOD 9604 is a synthetic peptide fragment (amino acids 176–191) derived from the C-terminus of human growth hormone (hGH). It is primarily studied for its potential to stimulate lipolysis (fat breakdown) and reduce body fat without the negative impacts on blood sugar, insulin, or IGF-1 associated with full-length hGH.Current Status and UsesClinical Development: Originally developed as a potential obesity treatment, its clinical development as a prescription drug was terminated in 2007 because it failed to demonstrate sufficient weight-loss efficacy in late-stage trials to gain approval.Research and Off-Label Use: Despite lacking regulatory approval for medical use, it is widely investigated in laboratories studying fat metabolism and is frequently sold online for off-label aesthetic or weight-management purposes.Athletic Regulations: Because it mimics the lipolytic properties of growth hormone, AOD 9604 is classified as a performance-enhancing drug and is banned by the World Anti-Doping Agency (WADA)

Early-stage trials and animal studies suggested AOD 9604 might target lipid metabolism pathways without causing the diabetogenic or growth-stimulating side effects typical of hGH. While some proponents advocate its use for breaking weight-loss plateaus or aiding targeted fat reduction, this relies mostly on anecdotal experience and early preclinical studies rather than robust, peer-reviewed clinical consensus